# Novartis’ TREM2 drug fails Phase 2 ALS trial

> **Open Intelligence Dossier** · First detected: 2026-09-16 17:20 UTC · Category: Business

## Executive Summary
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.

## Intelligence Brief
"Novartis’ TREM2 drug fails Phase 2 ALS trial" is generating significant coverage in the Business category, with 5 articles from 5 distinct sources tracked by PULSE so far.


Outlets currently covering the story include Reuters, Fierce Biotech, Investor's Business Daily and Bloomberg.com. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.


This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.

## Multi-Source Evidence Table
| Source Outlet | Headline | Verification URL |
|---|---|---|
| Reuters | Novartis halts ALS drug development after mid-stage trial failure | [Source Link](https://news.google.com/rss/articles/CBMi0wFBVV95cUxOXzQ0aGlxRTVDWHZadUloUUk2bGhfMDAxdEkybkI3VnhQeVpjeUREX2dNSU9hOGZRb0M2TWhDV1lLSXhDem9KRnQwQ0dtYkgwTEJtSmRfNlA1WUhkZ3VOcFgzbXRXWmNBWHA2RU1NdXI1el9LV05vVUNIeXJvYV9URUpzUmQ2ZzZiUnlUbzZ6cGhIcklldC0xeHVNa3c2eThjLUJYaVZ0X2NMV3JBTmFXSmFLemY1Qng3aHlnUVhqX3VlNUY0bGhKQlAtR0dYODE5bUJB?oc=5) |
| Fierce Biotech | Novartis ends ALS program after phase 2 flop, adding to R&D woes | [Source Link](https://news.google.com/rss/articles/CBMingFBVV95cUxQa3VXcGFxbEhpd1lDQ0hteXVzVTFjbzVGSnBCSG13akc3T0E3enRjams5RERTMVN1MkktX25hNGJKWnozRV9xUWxHRV9Na1IxRTk2TjJaMDktRDQ4c1pxVE1NN1N6Q1A2ZWZseWk5MHFoTmZXVl8zcXBuZnZkMGVuNVVhNzVmQWNuMWVKMkFGc0d3aGJweDZyTGtkb05SUQ?oc=5) |
| Investor's Business Daily | Novartis Suffers Another Setback After Stock-Rocking Failures | [Source Link](https://news.google.com/rss/articles/CBMie0FVX3lxTE5WVTQyeWdsYkF1TDFHaFQ2bE5jNktkR0l2aGVubjhKd0hCZHBkdW9uUHJPYmgxd3dPaGthOFJmX0NMNUZTMjV1cm9BZUFmSTNhUjlwdHVVS012aG9tdVpVWGNySlJMMVFuTE9rYlo3TE5fN2ZvX1RyQTNCMA?oc=5) |
| Bloomberg.com | Novartis Experimental Drug for ALS Fails in Another Pipeline Hit | [Source Link](https://news.google.com/rss/articles/CBMitgFBVV95cUxPVFRWM05TQlNEYTZXQTZnYmxnbmhuaTRadmt2NXNXOVBmSXFJcXVlNmlmU3QteUhsalZFREFTWlJmWW5MOFJVT3huUm85bEdaOXVFbE85d0NLS3N4dFRsRUUzVl9qMk80cmV5LWpDT0c1ZDRydjdxQmVOYlZ6dE9lbmZ0NHJMUkNhdFdOOGI4UnY1S2dZNjhsUGE3Y1JTYlRlanVoem9xb0tUbVpWeHBDRGVwUU12QQ?oc=5) |
| Endpoints News | Novartis’ TREM2 drug fails Phase 2 ALS trial | [Source Link](https://news.google.com/rss/articles/CBMidkFVX3lxTFBNMWxIYVBLaEtqSGVnaHZKSWw4M25Da1VWOGFIcU5wUUdVNng4OUxadFVXOS1veEExUldnX1VidWZEd2R0amZQUDdZdGRJbWdlajAxTWdfMlNUMFc1TXZwOGpSOXlWckZPanhSdHZ6cWZ0dExmNVE?oc=5) |

---
*Canonical Source: https://pulse.byoviral.com/trend/2026-09-16/novartis-trem2-drug-fails-phase-2-als-trial*